Cena / účetní hodnota společnosti Panbela Therapeutics
Jaká je hodnota metriky Cena / účetní hodnota společnosti Panbela Therapeutics?
Hodnota metriky Cena / účetní hodnota společnosti Panbela Therapeutics Inc. je -0.13
Jaká je definice metriky Cena / účetní hodnota?
Cena / učetní hodnota (Price to book ratio) je ukazatel, který vyjadřuje poměr mezi hodnotou společnosti a book value společnosti, což je hodnota čistých aktiv.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Cena / účetní hodnota společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Panbela Therapeutics
Čemu se věnuje společnost Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Firmy s metrikou cena / účetní hodnota podobnou společnosti Panbela Therapeutics
- Hodnota metriky Cena / účetní hodnota společnosti Personas Social je -0.13
- Hodnota metriky Cena / účetní hodnota společnosti Zhongtian International je -0.13
- Hodnota metriky Cena / účetní hodnota společnosti Pintec Technology Ltd je -0.13
- Hodnota metriky Cena / účetní hodnota společnosti Aladdin Healthcare Technologies SE je -0.13
- Hodnota metriky Cena / účetní hodnota společnosti Orchestra-Premaman S.A je -0.13
- Hodnota metriky Cena / účetní hodnota společnosti IDT International je -0.13
- Hodnota metriky Cena / účetní hodnota společnosti Panbela Therapeutics je -0.13
- Hodnota metriky Cena / účetní hodnota společnosti Shirpur Gold Refinery je -0.13
- Hodnota metriky Cena / účetní hodnota společnosti Guangdong Adway Construction () je -0.13
- Hodnota metriky Cena / účetní hodnota společnosti ParcelPal Technology je -0.13
- Hodnota metriky Cena / účetní hodnota společnosti Rentian Technology je -0.13
- Hodnota metriky Cena / účetní hodnota společnosti Diebold Nixdorf Inc je -0.12
- Hodnota metriky Cena / účetní hodnota společnosti Jaypee Infratech je -0.12